December 10, 2019

Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman and chairman of Ajman Executive Council, has launched the AED1 billion ($272 million) Thumbay Medicity project in the emirate.

He also inaugurated the Thumbay University Hospital at Thumbay Medicity, a new regional hub of futuristic medical education, state-of-the-art healthcare and research, built by the Thumbay Group, state news agency WAM reported on Monday.

The Thumbay University Hospital is a dedicated 100-bed long-term care and rehabilitation unit with an upcoming centre for oncology as well as 10 surgical"...

Continue Reading >

December 10, 2019

Dubai Health Authority (DHA) has announced plans to expand its services with a new four-storey building dedicated to 127 specialised outpatient clinics.

The Dubai Hospital building will include clinics in the fields of ophthalmology, internal medicine, orthopaedics, cardiovascular, endocrine, tumors, surgery, obstetrics and gynaecology, dental and reproductive medicine.

The DHA has signed a memorandum of understanding (MoU) with Emirates Islamic Bank to support the initiative by donating AED25 million to build the building.


Continue Reading >

December 9, 2019

Dubai Health Authority (DHA) has signed an agreement with India-based Apollo Hospitals Group, the largest integrated healthcare provider in the Afro-Asia region, for joint collaboration opportunities in the field of healthcare technology.

The MoU was signed by Humaid Al Qutami, the Director General of DHA, and Santosh Marathe, the COO of Apollo Hospitals in the presence of Group Chairman Dr Prathap C Reddy at the Apollo Hospitals Navi Mumbai facility.


Continue Reading >

December 9, 2019

Galderma today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational therapy nemolizumab for the treatment of pruritus associated with prurigo nodularis.

Prurigo nodularis is a rare, potentially debilitating, chronic skin condition with thick skin nodules covering large body areas and associated severe pruritus. It frequently leads to a severe quality of life impairment.

Nemolizumab is a first-in-class investigational monoclonal antibody that blocks signaling of IL-31. Galderma recently presented,"...

Continue Reading >

December 7, 2019

Dubai Health Authority (DHA) said it has signed a MoU with VPS Healthcare, a leading healthcare provider with 20 hospitals and over 125 medical centres in the Middle East, Europe and India, to boost co-operation and partnership and exchange experiences.

The DHA delegation is currently on an official visit to India and is meeting representatives of leading healthcare institutions across Kerala besides the cities of Bangalore and Mumbai.

The MoU is aimed at facilitating the knowledge transfer and collaboration in key healthcare areas, said Humaid Al Qutami, the Director General of the DHA after signing the deal with Dr Shamsheer Vayalil, Chairman and Managing Director of VPS Healthcare.

Continue Reading >

December 5, 2019

Vocera Communications, Inc. (NYSE:VCRA), a recognised leader in clinical communication and workflow solutions, today announced that the Ministry of Health and Prevention of the United Arab Emirates plans to standardise care team communication using Vocera technology. An expected enterprise-wide deployment of the Vocera smartphone app and the new Vocera Smartbadge is part of a strategic alignment aimed at improving care team collaboration, optimising operational efficiency,"...

Continue Reading >

December 4, 2019

The organics market has been witnessing a steady growth in the region, driven by the demand for healthier and chemical free products, experts at the 2018 Middle East Organic and Natural Expo Dubai said.

The expo was inaugurated by Dr. Thani bin Ahmed Al Zeyoudi, the UAE Minister of Climate Change & Environment, at the Dubai World Trade Center. The event, which will run until December 5, 2019, has served as a platform for organic products to get launched into the Middle Eastern market for 17 years now, with the support of IFOAM Organics International.

In keeping"...

Continue Reading >

December 3, 2019

Decades of evidence have proven cardiorespiratory fitness to be a leading predictor of longevity and future health. Yet it is one that has been largely overlooked within insurance customer health profiles. With the signing of the exclusive agreement between leading global reinsurer, Gen Re, and health technology software company, PAI Health, this is set to change.

PAI Health is known for its innovation in biometric sensing and algorithm development with unique data insights rooted in cardiorespiratory fitness. The company’s digital services are based on published"...

Continue Reading >

December 1, 2019

Think you're worth your weight in gold? A recently-launched campaign is challenging people to prove their worth by 'donating' their excess weight to feed the hungry, even as they work hard to reach slimming targets.

'Donate Your Weight', the 30-day campaign by wellness brand VLCC, was launched in the Middle East recently with Emirates Red Crescent. This coincides with a one-month anti-obesity drive of VLCC in 13 countries, where the company has a presence.

The initiative has been organised with the active involvement of the medical fraternity. Its"...

Continue Reading >

November 28, 2019

Eminent medical experts from the region gathered recently during the Second Middle East Breast Cancer Summit, which was held in the UAE, to discuss the latest clinical trial results for treating advanced breast cancer patients targeting both pre and post-menopausal patients with advanced breast cancer.

The event, which was organised by Novartis Oncology, was inaugurated by Dr Humaid Al Shamsi, head of the Emirates Oncology Society. During the panel discussion, Dr Al Shamsi pointed out that these clinical trials give more hope for pre and post-menopausal patients.

He said: “While breast cancer is the most common female cancer in the Middle East, many of those affected do not seek medical"...

Continue Reading >